- Advised entities on compliance in the 340B Drug Pricing Program
- Represented national health care manufacturers and providers in multiple state and federal false claims litigation, resulting in favorable resolutions for the clients
- Evaluated potential risks of proposed business arrangements for national health care providers
- Advised national health care companies on state and federal regulatory matters, including potential affirmative litigation options
- Advised a global health care company on a variety of issues in connection with its acquisition of several health plans and provider groups, including health care regulatory due diligence, health care regulatory advice regarding transaction structure and strategy, and preparation of regulatory notices and other filings.
- Advised multiple pharmacy benefit managers and insurers on compliance concerns raised by state regulators pursuing inquiries on PBM and pharmacy claims processing practices, including issues specific to specialty drug arrangements, MAC pricing, and compliance with state-specific insurance requirements.
Mintz is advising a consortium of investors in their approximately $4.1 billion acquisition of Kindred Healthcare, Inc. Mintz collaborates with corporate counsel and provides regulatory analysis for the deal, which will create two stand-alone companies.
Mintz advised a health care company on due diligence, structuring, and documentation related to the acquisition of a 13,000-employee long-term care pharmacy. Mintz attorneys counseled the client on privacy, regulatory, and licensing requirements.
Mintz secured a full release of a biopharmaceutical company in a Louisiana state court case over alleged inflated drug price reporting. The client agreed to a nuisance value settlement of the case, resolving claims its actions cost the state’s Medicaid program more than $20 million.
After CMS adopted a new Medicaid Managed Care Rule in April 2016, Mintz assisted its clients with inconsistencies in the enrollment requirements for affected providers. Mintz secured confirmation that CMS would recognize temporary agreements and continues to advise clients on compliance.
Mintz has served as national transaction counsel for over 20 years for a Fortune 250 company that is a leading provider of kidney care. Mintz attorneys handle corporate, health care regulatory, employment, litigation, tax, and other related issues for transactions across the country.